![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
在攻击性,复发性和耐火性朗格汉斯细胞囊细胞瘤中,克洛法拉宾单疗法
Deevyashali Parekh1,2, Howard Lin1,2, Akanksha Batajoo1,2
1Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.
British journal of haematology
|March 19, 2024
概括
克洛法拉宾在对初始治疗耐药的患者中显示出高效作为朗格汉斯细胞囊细胞症 (LCH) 的救援疗法. 这项研究突出了其在治疗耐火性LCH,特别是在儿童中的潜力.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 儿科血液学/瘤学
背景情况:
- 系统性朗格汉斯细胞囊细胞形成 (LCH) 是一个重大挑战,超过50%的患者无法通过标准的第一线治疗来治愈.
- 仅有有限的数据可为耐火或复发性LCH患者提供有效的救援疗法选择.
研究的目的:
- 评估克洛法拉宾单一疗法的疗效和安全性,作为系统性LCH患者的救援治疗.
- 评估不同年龄组 (儿童与成年人) 的反应率,并探索与分子标记物的潜在相关性.
主要方法:
- 对58名全身性LCH患者进行了回顾性分析,这些患者接受了克洛法拉宾单一治疗.
- 评估了客观反应率 (ORR),并对儿科和成人患者进行了亚组分析.
- 研究了BRAF V600E变体等位基因频率与临床反应的相关性.
主要成果:
- 克洛法拉宾单一治疗在整体队列中显示了高的系统客观反应率,达到92.6%.
- 与成年人 (83.3%) 相比,儿童的反应率 (93.8%) 较高.
- 周围血液中的BRAF V600E+变体等位基因频率与临床反应存在相关性.
结论:
- 克洛法拉宾是系统性LCH的活性救援疗法,包括在严重预治疗的患者中.
- 与其他救援策略相比,需要进行进一步的前性多中心试验,以确定最佳剂量,长期疗效和安全性.
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K